Comparison between direct factor Xa inhibitors and low-molecular-weight heparin for efficacy and safety in the treatment of cancer-associated venous thromboembolism: A meta-analysis | J Cancer Res Ther; 2020 Jan; 15(6): 1541-1546 | IMSEAR

Main content 1 Search 2 Footer 3

+A A -A High contrast

Comparison between direct factor Xa inhibitors and low-molecular-weight heparin for efficacy and safety in the treatment of cancer-associated venous thromboembolism: A meta-analysis

Yang, Min; Li, Jiang; Rui, Sun; Wang, Yanfeng; Haiyan, Xu; Boyan, Yang; Xiaoming, Wu; Lei, Yu.

J Cancer Res Ther ; 2020 Jan; 15(6): 1541-1546

Article | IMSEAR | ID: sea-213568

Key words

Cancer-related venous thromboembolism; direct-acting oral anticoagulants; efficacy; low-molecular-weight heparin; safety

Search on Google

Full text: 1 Index: IMSEAR Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Systematic_reviews Journal: J Cancer Res Ther Journal subject: Neoplasms / Therapeutics Year: 2020 Type: Article

Search on Google

Full text: 1 Index: IMSEAR Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Systematic_reviews Journal: J Cancer Res Ther Journal subject: Neoplasms / Therapeutics Year: 2020 Type: Article